3307 |
My Practice with Zilver PTX |
Bryan Ping-Yen Yan |
Apr. 20. 15 |
3306 |
Complex Cases: Complex Lesion with Resolute Onyx |
Seung-Woon Rha |
Apr. 20. 15 |
3305 |
How to Manage Complex SFA Lesions |
Seung-Whan Lee |
Apr. 20. 15 |
3304 |
Japanese Experience with Zilver PTX |
Hiroyoshi Yokoi |
Apr. 20. 15 |
3303 |
Optimizing Duration of Anti-platelet Therapy Following ACS |
Freek W.A. Verheugt |
Apr. 20. 15 |
3302 |
PLATO: Impact on the Management of ACS and Personalizing Treatment with Ticagrelor |
Gregg W. Stone |
Apr. 20. 15 |
3301 |
Zilver PTX 5-year Data: What Does It Mean to Clinical Practice? |
Mark W. Burket |
Apr. 20. 15 |
3300 |
Is Even Lower Even Better?: An Evidence Based Discussion |
Ki Hoon Han |
Apr. 20. 15 |
3299 |
Optimal Treatment in Femoropopliteal with Misago |
Seung-Woon Rha |
Apr. 20. 15 |
3298 |
Current EVT Market in Japan and Case Review of Misago |
Yoshinori Tsubakimoto |
Apr. 20. 15 |